RP-L102

· Rocket Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RP-L102, covering 2026-04-13 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102